Instructions for Aflubin tablets No. 48
Composition
active ingredients: 1 tablet contains: Gentiana D1 3.6 mg, Aconitum D6 37.2 mg, Bryonia D6 37.2 mg, Ferrum phosphoricum D12 37.2 mg, Acidum sarcolacticum D12 37.2 mg;
excipients: lactose monohydrate, potato starch, magnesium stearate.
Dosage form
Pills.
Main physicochemical properties: round, flat, white tablets with possible inclusions, with a dividing line.
Pharmacotherapeutic group
A complex homeopathic preparation.
Pharmacological properties
Pharmacodynamics.
The drug has a direct antiviral effect, and also stimulates the synthesis of interferon and the cellular link of immunity, which allows it to be used at different stages of the infectious process (both for prevention and treatment).
When used for medicinal purposes, the drug reduces chills and helps normalize body temperature; reduces inflammation of the upper respiratory tract, runny nose and cough; reduces headache and weakness; reduces pain in muscles and joints; activates the body's defenses; accelerates recovery, prevents the development of complications.
When used for preventive purposes, the drug strengthens the body's overall resistance; increases local immunity of the upper respiratory tract; reduces the likelihood of flu and colds.
Indication
For the prevention and treatment of flu and colds (acute respiratory viral infections).
In the complex treatment of inflammatory and rheumatic diseases with joint pain.
Contraindication
Hypersensitivity (allergy) to any component of the drug.
Interaction with other medicinal products and other types of interactions
Clinically significant interaction of Aflubin® with other drugs has not been established. The drug can be combined with any drugs and treatment methods.
Application features
1 tablet contains 227 mg of lactose monohydrate, therefore patients with rare hereditary forms of galactose intolerance, lactase deficiency or glucose-galactose malabsorption syndrome should consult a doctor before taking this medicine.
This medicine does not replace preventive vaccination against influenza.
At the beginning of treatment with the drug, a short-term exacerbation of existing symptoms of the disease (primary reaction) is possible. This reaction is usually temporary. If the symptoms do not disappear, the drug should be discontinued. After the disappearance of the primary reaction, the drug can be used again. If the symptoms worsen again, the drug should be discontinued.
Since Aflubin® contains natural plant components, a slight change in the taste and color of the tablet may occur during storage, which does not lead to a decrease in the quality and effectiveness of the drug.
Use during pregnancy or breastfeeding
There is currently no evidence of a special risk when using the drug during pregnancy or breastfeeding. During this period, the drug should be used with caution in cases where the expected benefit to the mother outweighs the possible risk to the fetus/child.
There are no data on the effect of the drug on reproductive function.
Ability to influence reaction speed when driving vehicles or other mechanisms
The drug does not affect the ability to drive vehicles and mechanical devices.
Method of administration and doses
1. Beginning of treatment (1–2nd day of illness with a cold or flu).
| Dosage | Treatment course |
| Adults and children aged 12 and over | 1 tablet | For the fastest improvement, take the drug 3 times a day for 1–2 days. |
| Children aged 5 to 12 years | ½ tablet |
If you continue to feel unwell, you should continue taking the drug according to the following schedule:
2. Continuation of treatment (3–7th day of illness or until recovery).
| Dosage | Treatment course |
| Adults and children aged 12 and over | 1 tablet | 2 times a day |
Children aged 5 to 12 years | ½ tablet |
3. Prevention
Planned prophylaxis at the beginning or before the expected peak of respiratory viral infection, as well as after exposure to provoking factors (after hypothermia or after contact with a person with influenza or a respiratory infection).
| Dosage | Treatment course |
| Adults and children aged 12 and over | 1 tablet | 2 times a day for up to 3 weeks |
| Children aged 5 to 12 years | ½ tablet |
To achieve maximum effect, Aflubin® should be taken 30 minutes before or 1 hour after a meal; it is recommended to hold the tablet in the mouth until completely dissolved.
Children
Use the medicine in children over 5 years of age.
For the treatment of children aged 2 to 5 years, Aflubin® can be used in the form of drops.
Overdose
No cases of overdose have been identified.
Side effects
In exceptional cases, allergic reactions (including rash, hyperemia, itching of the skin, urticaria) are possible in individuals with hypersensitivity to any component of the drug.
Expiration date
5 years.
Storage conditions
Store in the original cardboard packaging at a temperature not exceeding 30 °C.
Keep out of reach of children.
Packaging
12 tablets in a blister; 1 or 2, or 3, or 4 blisters in a cardboard box.
Vacation category
Without a prescription.
Producer
Richard Bittner AG.
Address
Ossiacherstrasse 7, A-9560 Feldkirchen, Austria.
